Dr. Damian Esteban Berezovsky, MD

Dr. Berezovsky practices at Honorhealth Neurology in Scottsdale, Arizona.

Dr. Berezovsky's NPI, 1144653437, was assigned on August 9, 2013. Dr. Berezovsky holds Arizona license 53907.

Dr. Berezovsky's primary practice is Honorhealth Neurology, at 3501 N Scottsdale Rd, Scottsdale, AZ 85251 in Maricopa County. The practice phone is (602) 258-3354.

Dr. Berezovsky's primary practice is Honorhealth Neurology in Scottsdale, Arizona. Dr. Berezovsky is also affiliated with HonorHealth John C. Lincoln Medical Center. The medical group on file is HonorHealth Medical Group. Dmand AI also links Dr. Berezovsky to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berezovsky practices, 2 sites in all. Vendor and product names are available with a free account.

Neuro-ophthalmology is Dr. Berezovsky's primary specialty in the NPI Registry, under taxonomy code 207WX0109X. Dmand AI has Dr. Berezovsky's licenses on file in 2 states: Arizona and Georgia.

CMS data shows 396 Medicare services from Dr. Berezovsky across 6 procedure codes in 2024, for 162 Medicare patients. Medicare paid $26,389 for them. Every service was in an office.

CMS counts 162 Medicare patients who saw Dr. Berezovsky in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berezovsky's median patient age at 61, with 68% women.

In 2023, Dr. Berezovsky wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $75 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

Dr. Berezovsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Berezovsky, published from 2011 to 2020. The most frequent topics are Rabbits, Choroid and Dextrans. Dr. Berezovsky has published most often in Br J Ophthalmol. Dr. Berezovsky's most frequent co-authors are Nancy Jean Newman, MD, Jason H. Peragallo, MD and Beau Benjamin Bruce, MD.

Dmand AI links Dr. Berezovsky to 1 clinical trial. Conditions studied include Pseudotumor Cerebri and Intracranial Hypertension.

CMS Open Payments shows 33 general payments to Dr. Berezovsky from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alexion Pharmaceuticals, Inc. paid the most, $364.